A Trial of Selinexor, Ruxolitinib and Methylprednisolone
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Selinexor
Related studies linked through entity extraction aliases.
Selinexor, Cyclophosphamide and Prednisone in Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Trial of Idasanutlin and Selinexor Therapy for Children With Progressive/Relapsed AT/RT or Extra-CNS Malignant Rhabdoid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) Patients
- Status
- UNKNOWN
- Phase
- PHASE2
SVRd for the Treatment of Newly Diagnosed Multiple Myeloma Patients Presenting With Extramedullary Disease
- Status
- RECRUITING
- Phase
- PHASE2
A Real-world Study of Selinexor-based Regimens for Treatment of Non-Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- N/A
An Open, Single Center, Non-randomized, Single Arm Clinical Study of Evaluating the Efficacy of Selinexor in the Maintenance Treatment of PTCL
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Selinexor and Lenalidomide for Consolidation and Maintenance Treatment in Multiple Myeloma Post-transplant
- Status
- WITHDRAWN
- Phase
- PHASE2
Selinexor and HAAG With/Without HMA in Relapsed/Refractory Acute Leukemia (AML) Patients
- Status
- UNKNOWN
- Phase
- NA
Selinexor Combined With R-GemOx as Second-line Treatment in Patients With Diffuse Large B-cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE4
Adaptive Treatment for Acute Myeloid Leukemia Based on D14 MRD Results
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Selinexor in Combination With Azacitidine and Venetoclax (SAV Regimen) in Treatment Naïve Participants With Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Selinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE3
Selinexor in Combination With MTX+Ritu to Treat R/R CNSL
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3